SEC 13F Intelligence

Norges Bank / CVS

Norges Bank’s Cvs Health Corp Position

Does Norges Bank own Cvs Health Corp (CVS)? Not currently — the last reported position was 21.00M shares worth $1.7B in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1.7B
Q4 2025
Shares
21.00M
% of Portfolio
+0.18%
Quarters Held
31
position exited

Position History CVS

Reported value by quarter
Q1 ’18: $622MQ1 ’18Q2 ’18: $653MQ3 ’18: $781MQ4 ’18: $840MQ1 ’19: $701MQ1 ’19Q2 ’19: $701MQ3 ’19: $808MQ4 ’19: $956MQ1 ’20: $767MQ1 ’20Q2 ’20: $903MQ3 ’20: $807MQ4 ’20: $965MQ1 ’21: $1.1BQ1 ’21Q2 ’21: $1.1BQ3 ’21: $1.1BQ4 ’21: $1.3BQ1 ’22: $1.4BQ1 ’22Q2 ’22: $1.3BQ3 ’22: $1.4BQ4 ’22: $1.4BQ1 ’23: $1.1BQ1 ’23Q2 ’23: $1.1BQ3 ’23: $1.0BQ4 ’23: $1.1BQ1 ’24: $1.2BQ1 ’24Q2 ’24: $880MQ3 ’24: $908MQ4 ’24: $840MQ1 ’25: $1.2BQ1 ’25Q2 ’25: $1.4BQ4 ’25: $1.7Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 202521.00M$1.7B+0.18%
Q2 202519.70M$1.4B+0.17%
Q1 202517.12M$1.2B+0.16%
Q4 202418.70M$840M+0.11%
Q3 202414.44M$908M+0.13%
Q2 202414.90M$880M+0.13%
Q1 202414.74M$1.2B+0.19%
Q4 202313.83M$1.1B+0.19%
Q3 202314.88M$1.0B+0.21%
Q2 202315.40M$1.1B+0.21%
Q1 202314.97M$1.1B+0.24%
Q4 202215.30M$1.4B+0.34%
Q3 202214.44M$1.4B+0.37%
Q2 202213.84M$1.3B+0.33%
Q1 202213.53M$1.4B+0.30%
Q4 202113.06M$1.3B+0.28%
Q3 202113.12M$1.1B+0.25%
Q2 202113.69M$1.1B+0.25%
Q1 202114.34M$1.1B+0.25%
Q4 202014.13M$965M+0.23%
Q3 202013.83M$807M+0.21%
Q2 202013.90M$903M+0.26%
Q1 202012.93M$767M+0.27%
Q4 201912.86M$956M+0.27%
Q3 201912.80M$808M+0.25%
Q2 201912.86M$701M+0.22%
Q1 201913.00M$701M+0.23%
Q4 201812.82M$840M+0.31%
Q3 20189.92M$781M+0.25%
Q2 201810.15M$653M+0.22%
Q1 201810.00M$622M+0.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of CVS.